Results 221 to 230 of about 104,078 (326)

Benefits of Nutrients and Phytonutrients in Nuts and Legumes on Platelet Aggregation Through DNA Methylation

open access: yesMolecular Nutrition &Food Research, Volume 69, Issue 24, December 2025.
Nuts and legumes contain both nutrients and bioactive compounds supporting cardiovascular health related to influencing DNA methylation. These foods are related to reducing oxidative stress, supplying methyl donors, and modulating genes involved in platelet function, such as PEAR1 and mitochondrial genes, in association with helping reduce inflammation
Siwaphorn Chaimati   +2 more
wiley   +1 more source

Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer. [PDF]

open access: yesJ Nucl Med
Young AJ   +19 more
europepmc   +1 more source

[Poly adenosine diphosphate-ribosylation and neurodegenerative diseases]. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban, 2020
Wang Y, Lu Y.
europepmc   +1 more source

Reagentless Real‐Time ATP Monitoring with New DNA Aptamers

open access: yesSmall, Volume 21, Issue 48, December 3, 2025.
A new aptamer is discovered via in vitro selection that binds to adenosine triphosphate (ATP) with high affinity (KD = 0.7 µm) and rejects closely related analogs including adenosine diphosphate (ADP), adenosine monophosphate (AMP), and adenosine. A fluorescent molecular beacon based on the aptamer enables continuous analyte monitoring in cell culture ...
Adara Bacon   +5 more
wiley   +1 more source

Inhibition of PAF-induced aggregation of human PMNs and platelets by adenosine: in vitro investigations using a newly developed blood filtration system [PDF]

open access: yes, 1992
Arbogast, Helmut   +7 more
core   +1 more source

The Challenges of Vascular Implants: Regulatory Strategies and Biological Responses

open access: yesSmall Science, Volume 5, Issue 12, December 2025.
Implantable vascular devices are revolutionizing the management of cardiovascular diseases, such as heart failure, by enabling real‐time monitoring and individualized therapy. However, their potential is challenged by regulatory constraints and biological barriers, as device implantation into a vessel can trigger inflammation, thrombosis, and long‐term
Serena Babboni   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy